Holder (CRGO) files Form 144: 20,000 shares proposed for sale (NASDAQ)

Rhea-AI Filing Summary

Reporting person filed a Form 144 proposing the sale of 20,000 Ordinary shares. The filing states the securities relate to restricted stock vesting under a registered plan and lists multiple recent dispositions by the holder in March–April 2026, including a 15,000-share sale on 04/28/2026 for $30,750.

Insights

Securities Compliance Officer

Form 144 signals a planned resale by a holder under registered-plan vesting; listed transactions show prior disposals in March–April 2026.

The filing lists 20,000 Ordinary shares proposed for sale tied to restricted stock vesting under a registered plan. It also records multiple completed dispositions by the same holder between 03/11/2026 and 04/28/2026, with transaction values stated for each trade.

These are procedural resale disclosures under Rule 144 reporting; cash‑flow treatment and whether sales were effected via broker/dealer are not specified in the excerpt. Subsequent filings will show final execution details.

Key Figures

Proposed shares to be sold: 20,000 shares Listed sale — 04/28/2026: 15,000 shares Listed sale — 04/17/2026: 10,000 shares +1 more

4 metrics

Proposed shares to be sold 20,000 shares stated as securities to be sold tied to restricted stock vesting

Listed sale — 04/28/2026 15,000 shares sale dated 04/28/2026 with proceeds listed as $30,750

Listed sale — 04/17/2026 10,000 shares sale dated 04/17/2026 with proceeds listed as $21,300

Earliest listed disposition 5,000 shares sale dated 03/11/2026 with proceeds listed as $6,300

Key Terms

Form 144, restricted stock vesting, registered plan, compensation

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock vesting financial

"Restricted stock vesting under a registered plan"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

registered plan regulatory

"Restricted stock vesting under a registered plan"

compensation financial

"Compensation"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	41000.00	51377000	05/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/01/2012	Restricted stock vesting under a registered plan	Issuer			20000	01/01/2012	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/28/2026	15000	30750.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/17/2026	10000	21300.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/15/2026	10000	18500.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/13/2026	10000	16200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/08/2026	10000	16900.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/01/2026	5000	8200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/30/2026	5000	8150.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/24/2026	10000	15850.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/17/2026	10000	16508.50
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/16/2026	10000	15214.04
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/11/2026	5000	6300.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CRGO Form 144 disclose about the securities being sold?

The Form 144 discloses a proposed sale of 20,000 Ordinary shares tied to restricted stock vesting under a registered plan. The filing lists the security type and the vesting origin as compensation.

Who appears as the selling holder in the Form 144 for CRGO?

The filing shows transactions by Zvi Schreiber (address listed) as the holder reporting multiple dispositions in March–April 2026. The excerpt names this individual for the listed past sales.

What recent sales are listed in the filing excerpt?

The excerpt records multiple sales between 03/11/2026 and 04/28/2026, including a 15,000-share sale on 04/28/2026 for $30,750 and other trades with stated proceeds.

Are the proceeds or cash‑flow recipient specified for the proposed 20,000 shares?

The filing identifies proceeds for listed past sales but does not state who receives proceeds for the proposed sale of 20,000 shares in the provided excerpt.

Is the proposed sale subject to any restriction noted in the excerpt?

The shares are described as from restricted stock vesting under a registered plan, which is the stated origin; the excerpt does not append additional qualifiers such as timing conditions or approvals.